Nitric oxide in neurodegeneration. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Nitric oxide in neurodegeneration.

Prog Brain Res. 1998;118:215-29. Unique Identifier : AIDSLINE MED/99131236
Dawson VL; Dawson TM; Department of Neurology, Johns Hopkins University School of; Medicine, Baltimore, MD 21287, USA. vdawson@orion.bs.jhmi.edu


Abstract: Nitric oxide (NO) is a unique biological messenger molecule which mediates diverse physiologic roles. NO mediates blood vessel relaxation by endothelium, immune activity of macrophages and neurotransmission of central and peripheral neurons. NO is produced from three NO Synthase (NOS) isoforms: Neuronal NOS (nNOS), endothelial NOS, and inducible NOS (iNOS). In the central nervous system, NO may play important roles in neurotransmitter release, neurotransmitter reuptake, neurodevelopment, synaptic plasticity, and regulation of gene expression. However, excessive production of NO following a pathologic insult can lead to neurotoxicity. NO plays a role in mediating neurotoxicity associated with a variety of neurologic disorders, including stroke, Parkinson's Disease, and HIV dementia.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Animal AIDS Dementia Complex/METABOLISM Cerebrovascular Disorders/METABOLISM Human Neurodegenerative Diseases/*METABOLISM Neurons/PHYSIOLOGY Nitrates/TOXICITY Nitric Oxide/*METABOLISM/*PHYSIOLOGY Nitric-Oxide Synthase/PHYSIOLOGY Parkinson Disease/METABOLISM Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S.KWDjournalarticlereviewreview,tutorialanimalaidsdementiacomplex/metabolismcerebrovasculardisorders/metabolismhumanneurodegenerativediseases/KWDmetabolismneurons/physiologynitrates/toxicitynitricoxide/KWDmetabolism/KWDphysiologynitric-oxidesynthase/physiologyparkinsondisease/metabolismsupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDs
990630
A9960688

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .